[Multifocal Tuberculosis Complicated by a Macrophage Activation Syndrome: About Two Cases]

Overview

Journal Pan Afr Med J

Date 2019 May 31

PMID 31143346

Authors

Rajae Azzeddine

Fatimazahra Elyassir

Jamal Eddine Bourkadi

Affiliations

Soon will be listed here.

Abstract

Macrophage activation syndrome (MAS) is a rare disorder due to an inappropriate stimulation of macrophages in the bone marrow and in the lymphoid organs. It is defined based on clinical and cytohistological criteria as well as on laboratory tests. Primary syndrome can occur mostly in children or it can be secondary to different types of disorders: haematological, infectious diseases as well as different types of autoimmune diseases. Prognosis is poor, with a mortality rate of almost 50% from all causes. Treatment is based on specific treatment dependent upon the causative agent of the MAS and, in some cases, on etoposide, corticosteroids and immunogobulines, which should be administered at an early stage. MAS has been rarely described in association with tuberculosis. We here report two cases: an immunocompromised patient, the first case, an immunocompetent patient with multifocal tuberculosis complicated by macrophage activation syndrome, the second case. This study aims to emphasize on difficulty in treating macrophage activation syndrome associated with tuberculosis, on the need for an evaluation of benefit/risk ratio based on corticosteroid or immunosuppressant-related risk for developing immunosuppression, with possible worsening of tuberculosis.

References

Imashuku S . Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol. 2000; 72(1):1-11. View

de Kerguenec C, Hillaire S, Molinie V, Gardin C, Degott C, Erlinger S . Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol. 2001; 96(3):852-7. DOI: 10.1111/j.1572-0241.2001.03632.x. View

Karras A, Hermine O . [Hemophagocytic syndrome]. Rev Med Interne. 2002; 23(9):768-78. DOI: 10.1016/s0248-8663(02)00673-2. View

Brastianos P, Swanson J, Torbenson M, Sperati J, Karakousis P . Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006; 6(7):447-54. DOI: 10.1016/S1473-3099(06)70524-2. View

Henter J, Horne A, Arico M, Egeler R, Filipovich A, Imashuku S . HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2006; 48(2):124-31. DOI: 10.1002/pbc.21039. View

Janka G . Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2006; 166(2):95-109. DOI: 10.1007/s00431-006-0258-1. View

Rouphael N, Talati N, Vaughan C, Cunningham K, Moreira R, Gould C . Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007; 7(12):814-22. PMC: 7185531. DOI: 10.1016/S1473-3099(07)70290-6. View

Creput C, Galicier L, Buyse S, Azoulay E . Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008; 34(7):1177-87. DOI: 10.1007/s00134-008-1111-y. View

Ishii E, Ohga S, Aoki T, Yamada S, Sako M, Tasaka H . Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol. 1991; 85(2):93-9. DOI: 10.1159/000204864. View

10.

Sandrini J, Beucher A, Rousselet M, Gardembas M, Lavigne C . [Tuberculosis with a hemophagocytic syndrome]. Med Mal Infect. 2009; 40(8):476-9. DOI: 10.1016/j.medmal.2009.09.003. View

11.

Le Ho H, Barbarot N, Desrues B . [Pancytopenia in disseminated tuberculosis: Think of macrophage activation syndrome]. Rev Mal Respir. 2010; 27(3):257-60. DOI: 10.1016/j.rmr.2010.02.005. View

12.

Reiner A, Spivak J . Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore). 1988; 67(6):369-88. View

13.

Esumi N, Ikushima S, Hibi S, Todo S, Imashuku S . High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer. 1988; 61(10):2071-6. DOI: 10.1002/1097-0142(19880515)61:10<2071::aid-cncr2820611023>3.0.co;2-6. View

14.

Quiquandon I, Plantier I, Hatron P, Chassaing O, Bauters F, Desablens B . Tuberculosis associated haemophagocytic syndrome: two cases with a favourable outcome. Nouv Rev Fr Hematol (1978). 1995; 37(2):149-52. View

15.

Cassim K, Gathiram V, Jogessar V . Pancytopaenia associated with disseminated tuberculosis, reactive histiocytic haemophagocytic syndrome and tuberculous hypersplenism. Tuber Lung Dis. 1993; 74(3):208-10. DOI: 10.1016/0962-8479(93)90014-O. View

16.

Undar L, Karpuzoglu G, Karadogan I, Gelen T, Artvinli M . Tuberculosis-associated haemophagocytic syndrome: a report of two cases and a review of the literature. Acta Haematol. 1996; 96(2):73-8. DOI: 10.1159/000203719. View

17.

Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T . Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol. 1997; 59(4):247-53. DOI: 10.1111/j.1600-0609.1997.tb00984.x. View